InvestorsHub Logo
Followers 51
Posts 9693
Boards Moderated 0
Alias Born 06/06/2009

Re: None

Saturday, 11/28/2020 9:50:26 AM

Saturday, November 28, 2020 9:50:26 AM

Post# of 28488
$PBIO Measurable success achieved in Q3 2020 in key financial, operational, and technical projects

Revenue increases reported in products and services offerings; balance sheet improved with significant reduction in variable-rate debt
Q3 total revenue exceeded Q1 and Q2 total revenue combined
Company reported receipt of 12 pre-orders for the innovative BaroShear K45, which is on track to be released in mid-2021
Alliance with Leica Microsystems over PBI’s proprietary pressure cycling technology (“PCT”) platform has the potential to accelerate cancer R&D and subsequent drug development using an innovative tumor processing workflow https://www.networknewswire.com/pressure-biosciences-inc-pbio-reports-revenue-hike-in-q3-while-achieving-its-best-financial-quarter-in-two-years-company-expects-strong-2021/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PBIO News